About the Book
Male Breast Cancer by Ian Fentiman provides an up-to-date review of the risk factors and genetics influencing the development of this rare disease. This second edition is fully updated and refreshed to include all recent important evidence from 2017-2024. It offers a structured format with a synopsis at the end of each chapter, presenting clinical features and recent advances in histopathology and molecular profiling.
This volume is a valuable aid to clinicians in tailoring treatment to both the patient and the tumour, offering insights into effective strategies for making or negating a diagnosis. The text examines surgical management and algorithms for local and systemic therapy, alongside evidence-based management for advanced or disseminated disease cases.
Readers will also find insights on determining prognosis and future developments for improved survival, ensuring a comprehensive understanding of the current landscape in male breast cancer care.
Key Themes & Topics Covered
- Detailed analysis of risk factors and genetics influencing disease development
- Recent advances in histopathology and molecular profiling for tailored treatment
- Strategies for effective diagnosis and negating false positives
- Discussion on psychological needs and support methods for men
- Examination of surgical management and algorithms for local and systemic therapy
- Evidence-based management for advanced or disseminated disease cases
- Insights on determining prognosis and future developments for improved survival
Who Should Read This?
This book is designed for a postgraduate audience, including breast surgeons, oncologists, breast radiologists, breast histopathologists, and breast care nurses. It serves as an essential reference for clinicians seeking to refine their approach to diagnosis and treatment planning for male patients.
Add this volume to your collection to stay informed on the latest evidence and strategies in male breast cancer management.



Reviews
There are no reviews yet.